MAX Chat
Company Analysis ЕМС
1. Summary
Advantages
- The stock's return over the last year (4.97%) is higher than the sector average (1.97%).
- Current debt level 14.28% is below 100% and has decreased over 5 years from 59.81%.
- The company's current efficiency (ROE=48.75%) is higher than the sector average (ROE=30.79%)
Disadvantages
- Price (754.7 ₽) is higher than fair price (403.08 ₽)
- Dividends (0%) are below the sector average (8.29%).
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| ЕМС | Потреб | Index | |
|---|---|---|---|
| 7 days | 1.5% | 6.3% | 6.8% |
| 90 days | 7.5% | 5.5% | 4.4% |
| 1 year | 5% | 2% | 4.7% |
GEMC vs Sector: ЕМС has outperformed the "Потреб" sector by 2.99% over the past year.
GEMC vs Market: ЕМС has outperformed the market by 0.3107% over the past year.
Stable price: GEMC is not significantly more volatile than the rest of the market on "Московская биржа" over the last 3 months, with typical variations of +/- 5% per week.
Long period: GEMC with weekly volatility of 0.0955% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (754.7 ₽) is higher than the fair price (403.08 ₽).
Price is higher than fair: The current price (754.7 ₽) is 46.6% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (5.2) is lower than that of the sector as a whole (17.85).
P/E vs Market: The company's P/E (5.2) is lower than that of the market as a whole (7.72).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (2.06) is lower than that of the sector as a whole (5.6).
P/BV vs Market: The company's P/BV (2.06) is higher than that of the market as a whole (1.22).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (2.13) is higher than that of the sector as a whole (1.19).
P/S vs Market: The company's P/S indicator (2.13) is higher than that of the market as a whole (1.12).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (4.15) is lower than that of the sector as a whole (4.57).
EV/Ebitda vs Market: The company's EV/Ebitda (4.15) is higher than that of the market as a whole (3.08).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 2810.56% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (2810.56%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-10.69%).
5.4. ROE
ROE vs Sector: The company's ROE (48.75%) is higher than that of the sector as a whole (30.79%).
ROE vs Market: The company's ROE (48.75%) is higher than that of the market as a whole (14.22%).
5.5. ROA
ROA vs Sector: The company's ROA (31.09%) is higher than that of the sector as a whole (14.65%).
ROA vs Market: The company's ROA (31.09%) is higher than that of the market as a whole (7.81%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (14.31%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (17.63%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '8.29%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.17.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (1.95%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
9. Stocks forum ЕМС
9.2. Latest Blogs
🏥 Сектор здравоохранения (предоставление медицинских услуг). Подробный обзор. Часть 1
🩺 Мать и Дитя #MDMG
Текущая цена: 1050,8₽
Целевая цена: 1200₽
Потенциал роста: 14,1%
📈 Сильные стороны:
- стабильное финансовое положение.
- регулярные дивиденды.
- лидирующие позиции на рынке.
- рост бизнеса: M&A сделки + открытие новых клиник.
📉 Слабые стороны:
- снижение потока клиентов....
More
Близость рецессии одна из главных тем на ПМЭФ. Оптимизма становится меньше
Во время проведения ПМЭФ российский фондовый рынок обычно растет, но не в этот раз. Поток новостей оттуда расстраивает инвесторов. По итогам основной сессии индекс МосБиржи просел на 0,4% и составил 2780,69 п., индекс РТС потерял 0,1% - до 1116,12 п....
More
💊 Сектор здравоохранения – Подробный обзор
📌 Продолжаем обзор секторов компаний Мосбиржи, и сегодня посмотрим на сектор здравоохранения. Напомню, ранее я делал обзоры нефтегазового сектора, банков, IT-компаний, ритейлеров, золотодобытчиков, удобрений, энергетиков, транспорта, металлургов и застройщиков....
More
All blogs ⇨
